NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,887,683 | -86.4% | 178,804 | -65.1% | 0.00% | -85.7% |
Q2 2023 | $21,232,549 | -20.0% | 511,628 | +15.9% | 0.01% | -22.2% |
Q1 2023 | $26,553,789 | -27.9% | 441,532 | -12.1% | 0.01% | -35.7% |
Q4 2022 | $36,837,705 | -9.8% | 502,219 | -6.6% | 0.01% | -12.5% |
Q3 2022 | $40,846,000 | +2.2% | 537,594 | -6.5% | 0.02% | +14.3% |
Q2 2022 | $39,960,000 | -8.5% | 574,966 | +9.1% | 0.01% | +7.7% |
Q1 2022 | $43,655,000 | +3.1% | 526,915 | -6.6% | 0.01% | 0.0% |
Q4 2021 | $42,340,000 | -35.1% | 563,937 | +0.4% | 0.01% | -38.1% |
Q3 2021 | $65,253,000 | -47.0% | 561,705 | +1.3% | 0.02% | -48.8% |
Q2 2021 | $123,008,000 | +79.1% | 554,541 | +6.7% | 0.04% | +57.7% |
Q1 2021 | $68,685,000 | +34.1% | 519,637 | +75.6% | 0.03% | +30.0% |
Q4 2020 | $51,218,000 | +393.8% | 295,984 | +217.7% | 0.02% | +300.0% |
Q3 2020 | $10,372,000 | +93.7% | 93,173 | +3.1% | 0.01% | +66.7% |
Q2 2020 | $5,356,000 | +33.6% | 90,339 | +52.1% | 0.00% | +50.0% |
Q1 2020 | $4,009,000 | -16.7% | 59,375 | +3.9% | 0.00% | 0.0% |
Q4 2019 | $4,815,000 | +27.7% | 57,137 | +13.3% | 0.00% | 0.0% |
Q3 2019 | $3,770,000 | +48.3% | 50,428 | +25.4% | 0.00% | +100.0% |
Q2 2019 | $2,543,000 | +60.9% | 40,219 | +22.6% | 0.00% | 0.0% |
Q1 2019 | $1,580,000 | +46.6% | 32,804 | +1.9% | 0.00% | 0.0% |
Q4 2018 | $1,078,000 | -26.6% | 32,192 | +14.9% | 0.00% | 0.0% |
Q3 2018 | $1,469,000 | +69.2% | 28,027 | +1.1% | 0.00% | 0.0% |
Q2 2018 | $868,000 | +94.2% | 27,726 | +35.1% | 0.00% | – |
Q1 2018 | $447,000 | -7.3% | 20,523 | -13.9% | 0.00% | – |
Q4 2017 | $482,000 | -4.0% | 23,845 | -4.8% | 0.00% | – |
Q3 2017 | $502,000 | +110.9% | 25,045 | +80.6% | 0.00% | – |
Q2 2017 | $238,000 | +128.8% | 13,866 | +8.5% | 0.00% | – |
Q1 2017 | $104,000 | +4.0% | 12,774 | -1.3% | 0.00% | – |
Q4 2016 | $100,000 | – | 12,942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |